Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for TRML

Stock NameTourmaline Bio Inc.
TickerTRML(USD) NASDAQ
TYPECommon Stock
CountryUSA

Show aggregate TRML holdings

News associated with TRML

Truist Financial Downgrades Tourmaline Bio (NASDAQ:TRML) to Hold
Tourmaline Bio (NASDAQ:TRML – Get Free Report) was downgraded by equities research analysts at Truist Financial from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, Marketbeat Ratings reports. They presently have a $48.00 price target on the stock, down from their previous price target of […] - 2025-09-11 05:14:52
Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts
The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures... - 2025-09-10 13:24:04
Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts
The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures... - 2025-09-10 11:56:00
Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts
The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures... - 2025-09-10 10:14:58
Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts
The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures... - 2025-09-10 08:35:12
Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts
The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures... - 2025-09-10 06:54:32
Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts
The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures... - 2025-09-10 03:39:30
Tourmaline Bio, Inc. (NASDAQ:TRML) Receives $50.14 Average Target Price from Analysts
Shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) have been assigned an average rating of “Moderate Buy” from the eight analysts that are presently covering the firm, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average […] - 2025-09-10 02:32:51
Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts
The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures... - 2025-09-10 00:27:19
Stocks Edge Higher on Expectations for Fed Rate Cuts
The S&P 500 Index ($SPX ) (SPY ) today is up +0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.07%, and September E-mini Nasdaq futures... - 2025-09-09 14:59:32
Stocks Turn Mixed as US Job Growth Less Than Previously Stated
The S&P 500 Index ($SPX ) (SPY ) today is up +0.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.07%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.08%. September E-mini S&P futures (ESU25 ) are down -0.08%, and September E-mini Nasdaq futures... - 2025-09-09 14:45:23
Stocks Edge Higher on Expectations for Fed Rate Cuts
The S&P 500 Index ($SPX ) (SPY ) today is up +0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.19%. September E-mini S&P futures (ESU25 ) are up +0.07%, and September E-mini Nasdaq futures... - 2025-09-09 12:48:35
Tourmaline Bio Agrees To Be Acquired By Novartis In $1.4 Bln Deal; Stock Up
(RTTNews) - Tourmaline Bio Inc. (TRML) announced Tuesday that it has agreed to be acquired by Novartis AG (NVS, NOVN.SW) for $48.00 per share in cash at closing, representing a total equity value of about $1.4 billion. The deal price represents a premium of 59% to Tourmalines clo - 2025-09-09 02:28:03
Federated Hermes Inc. Buys 120,322 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML)
Federated Hermes Inc. increased its stake in shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 13,036.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 121,245 shares of the company’s stock after acquiring an additional 120,322 shares during the quarter. Federated Hermes Inc.’s […] - 2025-08-06 05:13:00
Tourmaline Bio, Inc. (NASDAQ:TRML) Receives $49.33 Consensus PT from Analysts
Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) has received an average rating of “Buy” from the seven analysts that are presently covering the firm, MarketBeat reports. Seven equities research analysts have rated the stock with a buy rating. The average 12 month price target among analysts that have covered the stock in the last […] - 2025-06-27 02:37:04
GAMMA Investing LLC Grows Stake in Tourmaline Bio, Inc. (NASDAQ:TRML)
GAMMA Investing LLC grew its stake in shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 4,481.7% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 7,514 shares of the company’s stock after acquiring an additional 7,350 shares during the quarter. GAMMA Investing LLC’s holdings in Tourmaline Bio were worth $114,000 at the […] - 2025-06-24 04:46:55
SG Americas Securities LLC Has $550,000 Stock Position in Tourmaline Bio, Inc. (NASDAQ:TRML)
SG Americas Securities LLC lifted its position in Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 3.9% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 36,180 shares of the company’s stock after buying an additional 1,368 shares during the quarter. SG Americas […] - 2025-06-23 04:58:58
California State Teachers Retirement System Has $213,000 Stake in Tourmaline Bio, Inc. (NASDAQ:TRML)
California State Teachers Retirement System increased its stake in shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 527.9% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 10,505 shares of the company’s stock after buying an additional 8,832 shares during the quarter. California State Teachers Retirement System’s holdings in Tourmaline Bio were […] - 2025-06-13 05:02:51
Tourmaline Bio, Inc. (NASDAQ:TRML) Receives $49.33 Consensus PT from Brokerages
Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) has been given an average rating of “Buy” by the seven ratings firms that are covering the firm, Marketbeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average 12 month price target among brokers that have issued ratings on the stock in the […] - 2025-06-02 03:09:00
Millennium Management LLC Has $7.40 Million Stock Holdings in Tourmaline Bio, Inc. (NASDAQ:TRML)
Millennium Management LLC lowered its position in shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 28.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 364,658 shares of the company’s stock after selling 144,757 shares during the quarter. Millennium […] - 2025-05-27 04:48:57
Head-To-Head Analysis: Tourmaline Bio (NASDAQ:TRML) vs. enGene (NASDAQ:ENGN)
Tourmaline Bio (NASDAQ:TRML – Get Free Report) and enGene (NASDAQ:ENGN – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, risk and dividends. Institutional & Insider Ownership 91.9% of Tourmaline Bio […] - 2025-05-14 02:20:48
Analysts Set Tourmaline Bio, Inc. (NASDAQ:TRML) Target Price at $49.33
Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) has been assigned a consensus rating of “Buy” from the seven brokerages that are covering the firm, Marketbeat Ratings reports. Seven equities research analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have covered the stock in the last […] - 2025-05-08 02:04:55
Barclays PLC Acquires 26,733 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML)
Barclays PLC grew its holdings in shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 84.0% during the fourth quarter, Holdings Channel reports. The firm owned 58,566 shares of the company’s stock after purchasing an additional 26,733 shares during the period. Barclays PLC’s holdings in Tourmaline Bio were worth $1,187,000 as of its most […] - 2025-05-05 05:18:49
Tourmaline Bio (NASDAQ:TRML) Earns Buy Rating from Analysts at Chardan Capital
Stock analysts at Chardan Capital began coverage on shares of Tourmaline Bio (NASDAQ:TRML – Get Free Report) in a report issued on Wednesday, Marketbeat reports. The brokerage set a “buy” rating and a $70.00 price target on the stock. Chardan Capital’s price objective would indicate a potential upside of 304.16% from the company’s current price. […] - 2025-04-25 04:24:47
Vanguard Group Inc. Acquires 43,652 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML)
Vanguard Group Inc. boosted its stake in shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 4.1% in the 4th quarter, HoldingsChannel reports. The fund owned 1,106,125 shares of the company’s stock after buying an additional 43,652 shares during the quarter. Vanguard Group Inc.’s holdings in Tourmaline Bio were worth $22,432,000 at the end […] - 2025-04-16 04:28:51
Head to Head Survey: Tourmaline Bio (NASDAQ:TRML) vs. Vaxcyte (NASDAQ:PCVX)
Vaxcyte (NASDAQ:PCVX – Get Free Report) and Tourmaline Bio (NASDAQ:TRML – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations. Profitability This table compares Vaxcyte and Tourmaline Bio’s net […] - 2025-02-21 04:34:51

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc TRML holdings

DateNumber of TRML Shares HeldBase Market Value of TRML SharesLocal Market Value of TRML SharesChange in TRML Shares HeldChange in TRML Base ValueCurrent Price per TRML Share HeldPrevious Price per TRML Share Held
2025-09-29 (Monday)19,412USD 934,882USD 934,882
2025-09-26 (Friday)19,412USD 926,729USD 926,729
2025-09-25 (Thursday)19,412USD 926,341TRML holding decreased by -582USD 926,3410USD -582 USD 47.72 USD 47.75
2025-09-24 (Wednesday)19,412USD 926,923USD 926,923
2025-09-17 (Wednesday)19,288USD 920,038TRML holding decreased by -192USD 920,0380USD -192 USD 47.7 USD 47.71
2025-09-16 (Tuesday)19,288USD 920,230USD 920,230
2025-09-12 (Friday)19,164USD 912,398USD 912,398
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of TRML by Blackrock for IE00B3VWM098

Show aggregate share trades of TRML

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-08-21SELL-77 23.060* 16.87 Profit of 1,299 on sale
2025-07-31BUY231 22.130* 16.80
2025-06-30SELL-154 15.990* 16.60 Profit of 2,557 on sale
2025-06-25SELL-77 16.990* 16.60 Profit of 1,278 on sale
2025-06-20SELL-154 16.640* 16.59 Profit of 2,555 on sale
2025-05-23BUY77 15.320* 16.35
2025-05-19SELL-77 16.630* 16.38 Profit of 1,261 on sale
2025-05-15SELL-231 15.520* 16.38 Profit of 3,785 on sale
2025-05-12SELL-77 15.780* 16.41 Profit of 1,264 on sale
2025-05-09SELL-77 15.100* 16.43 Profit of 1,265 on sale
2025-04-30SELL-77 17.210* 16.45 Profit of 1,267 on sale
2025-04-24SELL-154 17.320* 16.43 Profit of 2,531 on sale
2025-04-17SELL-77 16.010* 16.41 Profit of 1,263 on sale
2025-04-15SELL-231 14.930* 16.46 Profit of 3,801 on sale
2025-04-14SELL-231 14.090* 16.49 Profit of 3,810 on sale
2025-04-09SELL-312 12.475* 16.68 Profit of 5,203 on sale
2025-04-07SELL-546 12.620* 16.81 Profit of 9,180 on sale
2025-04-04BUY6,474 12.830* 16.88
2025-03-31BUY55 15.210* 17.01
2025-03-19SELL-110 16.480* 17.03 Profit of 1,873 on sale
2025-03-14SELL-330 18.800* 16.96 Profit of 5,595 on sale
2025-03-13SELL-110 17.040* 16.95 Profit of 1,865 on sale
2025-03-12SELL-1,870 16.270* 16.97 Profit of 31,732 on sale
2025-03-07SELL-110 14.380* 17.11 Profit of 1,882 on sale
2025-03-06SELL-165 14.330* 17.18 Profit of 2,834 on sale
2025-03-03SELL-55 12.330* 17.54 Profit of 965 on sale
2025-02-28SELL-330 13.090* 17.66 Profit of 5,828 on sale
2025-02-26SELL-55 12.940* 17.94 Profit of 986 on sale
2025-02-25SELL-165 12.550* 18.09 Profit of 2,986 on sale
2025-02-18BUY275 13.140* 19.06
2025-02-13BUY55 13.090* 19.69
2025-02-12BUY55 13.230* 19.95
2025-02-11BUY165 12.880* 20.24
2025-02-06BUY495 14.990* 21.08
2025-01-27BUY55 17.000* 24.02
2024-12-06BUY220 25.930* 25.11
2024-12-05BUY55 24.030* 25.27
2024-12-04BUY275 25.585* 25.21
2024-11-29BUY275 26.040* 25.05
2024-11-27BUY220 25.660* 23.82
2024-11-26BUY55 23.820* 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of TRML

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1943,83734100,25143.7%
2025-09-1867,782131487,08613.9%
2025-09-1776,55511180,55442.4%
2025-09-1629,51333398,58129.9%
2025-09-1570,03461229,95530.5%
2025-09-1268,336128223,15430.6%
2025-09-11108,0551,447313,82434.4%
2025-09-10107,2215,190545,01019.7%
2025-09-092,215,9937,8868,384,88026.4%
2025-09-08137,88267328,34942.0%
2025-09-0594,1120199,58247.2%
2025-09-0489,1830120,77673.8%
2025-09-0388,5750113,16578.3%
2025-09-0249,504056,25688.0%
2025-08-2942,240049,47385.4%
2025-08-2820,280428,86570.3%
2025-08-2738,845052,65073.8%
2025-08-2631,462042,61873.8%
2025-08-2516,134021,95273.5%
2025-08-2223,826036,71564.9%
2025-08-2124,85970139,32263.2%
2025-08-2014,5521824,24460.0%
2025-08-1926,999034,33278.6%
2025-08-1886,63512124,81669.4%
2025-08-1515,3844732,47847.4%
2025-08-1421,14315037,70256.1%
2025-08-1325,77817838,03267.8%
2025-08-1230,0792946,95864.1%
2025-08-1125,11012105,20623.9%
2025-08-0832,9961,08593,34535.3%
2025-08-0742,833054,08479.2%
2025-08-0635,063068,01151.6%
2025-08-0529,4801646,58563.3%
2025-08-0419,5487371,73627.2%
2025-08-0142,5622887,35548.7%
2025-07-3172,28856135,59053.3%
2025-07-3060,32420295,90262.9%
2025-07-29312,855233432,37472.4%
2025-07-2895,69751250,79538.2%
2025-07-2549,67316115,22743.1%
2025-07-2426,07937491,33428.6%
2025-07-2317,642046,23338.2%
2025-07-2214,46034827,16453.2%
2025-07-2118,96620324,32778.0%
2025-07-1819,195040,33847.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.